BIIB Biogen Inc

Biogen Inc is a biopharmaceutical company. It is engaged in discovering, developing, manufacturing and delivering therapies to patients for the treatment of neurological, rare and autoimmune diseases.

$276.57  +78.78 (39.83%)
As of 09/28/2022 15:59:59 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Large cap
GICS sector:  Health Care
Industry:  Drug Manufacturers—General
Index country:  USA
Country of incorporation:  USA
IPO date:  02/08/2001
Outstanding shares:  145,113,047
Average volume:  1,032,370
Market cap:   $28,405,878,950
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
Sedol:      2455965
Valuation   (See tab for details)
PE ratio:   19.80
PB ratio:   2.59
PS ratio:   2.63
Return on equity:   12.90%
Net income %:   13.40%

2022 © Stock Market MBA, Inc. Terms of use | Privacy policy